NCT00075244View on ClinicalTrials.gov

Alternative Dosing and Regimen of Replagal to Treat Fabry Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

November 30, 2005

Conditions
Fabry Disease
Interventions
DRUG

Replagal

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00075244 - Alternative Dosing and Regimen of Replagal to Treat Fabry Disease | Biotech Hunter | Biotech Hunter